home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification
prev / next
 
 

registry of biomedical companies

  
  August 12, 2020
promoting the transfer of scientific know-how between industry and academia
  
 
Registry of biomedical companies:

[3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [Z] 515 active entries

EXCENEN PHARMATECH CO., LTD

P.O.: 510663 Rm411, Area A, No. 80, Science and Te
Guangzhou City, Guangdong Province, CN
China

Phone: 86 20 85653352
Fax: 86 20 85653397
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

Excenen PharmaTech is a high-tech research company dedicated in new molecules research and development for pharmaceutical enterprises, biochemical companies, medicinal research institutes, universities.


Our featured compounds:

Acumapimod (BCT-197) 836683-15-9
SGC2085 1821908-48-8
WIKI4 838818-26-1
   
TCS OX2 29 372523-75-6
Stattic 19983-44-9
   
S0859 1019331-10-2
Cyantraniliprole 736994-63-1
CZ415 1429639-50-8
ID-8 147591-46-6
PLX8394 1393466-87-9
Cloethocarb 51487-69-5
Morantel Citrate 69525-81-1
SCH58261 160098-96-4
RO0921 1446790-62-0
OTS514 1338540-63-8
OTS964 1338545-07-5
Ochratoxin-A 1448049-50-0
BTB06584 219793-45-0
AG 555 133550-34-2
AZD3293 1383982-64-6
MLN 4924 905579-51-3
BGB-283 1446090-77-2
GNE-140 2003234-63-5
T006 1415666-63-5
Eniporide 176644-21-6
N-(5-bromo-2-methoxypyridin-3-yl)-2,4-difluorobenzenesulfonamide 1086063-46-8
1-(4-fluorobenzoyl)cyclopropanecarboxylic acid 1191284-11-3
Benzamide, 4-methyl-N-(methylsulfonyl)- (9CI) 827624-81-7
Idrocilamide 6961-46-2
CEP-32496 (free base) 1188910-76-0
SGX-523 1022150-57-7
MSDC-0160(CAY10415) 146062-49-9
(S)-6-bromo-1-sec-butyl-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-1H-indole-4-carboxamide 1346574-54-6
T003 1414378-14-5
2-(4-((9S,13S)-9,13-Bis(Tert-Butoxycarbonyl)-18,18-Dimethyl-3,11,16-Trioxo-17-Oxa-2,4,10,12-Tetraazanonadecyl)Phenyl)Acetic Acid 1610413-97-2
3-[(6,7-dimethoxy-4-quinazolinyl)oxy]aniline 1188908-37-3
Levofloxacin 100986-85-4
Pentamidine-d4 2HCl 50357-45-4
FR180204 865362-74-9
BAY 11-7082 19542-67-7
WZB117 1223397-11-2
3-(Methoxymethoxy)propanal 109066-05-9
1,1,2,2-Tetraphenylethene 632-51-9
CY3.5 1284240-77-2
CY5.5 210892-23-2
CY7 943298-08-6
Dimebolin 3613-73-8
HA-1100  105628-72-6
MG-132 133407-82-6
UNC3866 1872382-47-2
BV6 1001600-56-1
MM-102 1417329-24-8
ZINC00881524 (ROCK inhibitor) 557782-81-7
VH-298 2097381-85-4
VcMMAE 646502-53-6
SC-560 188817-13-2
3-TYP 120241-79-4
Belizatinib (TSR011) 1357920-84-3
H3B-6527 1702259-66-2
Lanifibranor  927961-18-0
MBX-8025 (Seladelpar) 851528-79-5
SGI-7079 1239875-86-5
BI-882370 1392429-79-6
Brequinar 96187-53-0
CBP-307 N/A
PST2744 203737-93-3
SCR-1438 1174046-76-4
TP353 1253799-29-9
CG347B 1598426-03-9
CPFX2090 1429439-25-7
CPFX1302 N/A
LSP-249 1801253-04-2
ACT-1002-1237 N/A
ZN2007-RM1 N/A
TBAJ-587-1 N/A
TP-4748 1150114-62-7
CG378P N/A
CG378M N/A
TP748 951698-15-0
THZ2 1604810-84-5
THZ531 1702809-17-3
FM-381 N/A
INNO-406 859212-16-1
IOX4 1154097-71-8
GDC-0941 957054-30-7
Autophinib 1644443-47-9
NG25 1315355-93-1
SNS-062 1270014-40-8
AcycloA 31383-66-1
CEP-28122 1022958-60-6
Elvitegravir 697761-98-1
CEP-37440 1391712-60-9
GSK2334470 1227911-45-6
HA130 1229652-21-4
AM281 202463-68-1
AM630 164178-33-0
AZD7762 860352-01-8
AZD8055 1009298-09-2
BGJ-398,NVP-BGJ398,Infigratinib 1310746-10-1
BMS-911543 1271022-90-2
CEP-32496 HCl salt 1227678-26-3
CH5424802 HCl salt, Alectinib HCl salt, AF802 HCl salt 1256589-74-8
Cilomilast, SB 207499, Ariflo 153259-65-5
CUDC-305, Debio 0932 1061318-81-7
Erismodegib Diphosphate, NVP-LDE225 (diphosphate salt) 1218778-77-8
GDC-0941 bimesylate salt, Pictilisib dimethanesulfonate 957054-33-0
GNE-317 1394076-92-6
GSK2118436 Ms salt, Dabrafenib Ms salt, GSK2118436A Ms salt 1195768-06-9
HSP990, NVP-HSP990 934343-74-5
I-BET151 (GSK1210151A) 1300031-49-5
IPI-145, INK 1197, Duvelisib 1201438-56-3
LDK378 dihydrochloride, Ceritinib dihydrochloride 1380575-43-8
Mavoglurant, AFQ056 543906-09-8
MI-2, Menin-MLL inhibitor 2 1271738-62-5
MK-2461 917879-39-1
NVP-BKM120 HCl salt 1312445-63-8
TAK-960 HCl salt 1137868-96-2
Talampanel, GYKI-53773; LY-300164 161832-65-1
VX-11e 896720-20-0
XL388 1251156-08-7
LGB-321 1210417-75-6
Afuresertib HCl salt, GSK-2110183 HCl salt, GSK-2110183B HCl salt 1047645-82-8
Afuresertib, GSK-2110183, GSK-2110183B 1047644-62-1
AMG 511 1253573-53-3
AZD0530, Saracatinib 379231-04-6
AZD9291 Ms salt, Osimertinib Ms salt; Mereletinib Ms salt 1421373-66-1
AZD4547 1035270-39-3
Dinaciclib (SCH 727965) 779353-01-4
Decernotinib,VX-509 944842-54-0
GDC-0032, Taselisib; RG-7604 1282512-48-4
A-1210477 1668553-26-1
EPZ011989 1598383-40-4
CO-1686 HBr salt,Rociletinib HBr salt; AVL-301 HBr salt, CNX-419 HBr salt 1446700-26-0
LEE-011 HCl salt, Ribociclib HCl salt 1211443-80-9
LEE-011 succinate salt, Ribociclib succinate salt 1374639-75-4
LGX818, Encorafenib 1269440-17-6
LY2835219 Ms salt, Abemaciclib Ms salt 1231930-82-7
MK-0731 845256-65-7
NMS-1286937,NMS-P937 1034616-18-6
P505-15 HCl salt, PRT062607 HCl salt,PRT-2607 HCl salt, BIIB-057 HCl salt 1370261-97-4
P505-15, PRT062607,PRT-2607, BIIB-057 1370261-96-3
Uprosertib , GSK2141795 1047634-65-0
Uprosertib HCl salt, GSK2141795 HCl salt 1047635-80-2
WEHI-539 ( CT-WE539) 1431866-33-9
XL-228 898280-07-4
AZD3147 1101810-02-9
CCT196969 1163719-56-9
Danusertib, PHA-739358 827318-97-8
EPZ011989 TFA salt 1598383-41-5
EPZ020411 1700663-41-7
Oclacitinib,PF-03394197 1208319-26-9
PFI-2 1627676-59-8
PFI-2 HCl salt 1627607-87-7
AG-881,Mutant IDH1-IN-2 1429176-69-1
BAY-1436032 1803274-65-8
CCT-245737 1489389-18-5
Cenicriviroc 497223-25-3
CFI-400945, 1338806-73-7
CHZ868 1895895-38-1
CNDAC 135598-68-4
CPI-0610 1380087-89-7
EPZ031686 1808011-22-4
GDC-0994 1453848-26-4
I-181 N/A
PF-2771 N/A
Sapacitabine 151823-14-2
Selonsertib HCl salt, GS-4997 HCl salt 1448428-05-4
LX1606 Hippurate, Telotristat Etiprate 1137608-69-5
Telotristat, LP778902 1033805-28-5
CH5424802 analog 1256577-71-5
GSK-923295 8R-ISOMER N/A
AMG 511 RACEMATES N/A
AZD5363 RACEMATE N/A
CEP-37440 R-ISOMER N/A
　 　
GS-9901 R-ISOMER N/A
Upadacitinib, ABT-494 1310726-60-3
D- Luciferin Potsossium salt 115144-35-9
Lonafarnib 193275-84-2
NVP-HDM201; HDM201 1448867-41-1
S-63845 1799633-27-4
APD334 1206123-37-6
CCT251236 1693731-40-6
AF-353 865305-30-2
MK 0557 328232-95-7
Tandutinib 387867-13-2
LY3009120 1454682-72-4
I-BRD9 1714146-59-4
EGF816 1508250-71-2
GSK-3326595;EPZ-015938 1616392-22-3
Dovitinib lactate(TKI258) 915769-50-5
Niraparib tosylate 1038915-73-9
Cariprazine hydrochloride 1083076-69-0
TGR1202 1532533-67-7
GLPG1690 1628260-79-6
PTC-028 1782970-28-8
Takinib 1111556-37-6
AZD8186 1627494-13-6
LGD-6972 1207989-09-0
KDM5-C70 1596348-32-1 
BI-9564 1883429-22-8
　 　
Lasmiditan succinate 439239-92-6
TLR7-IN-1 1642857-69-9
ACC-789 300842-64-2
BMT-145027 2018282-44-3
GDC-0152 873652-48-3
Emricasan 254750-02-2
PF-05175157 1301214-47-0
Naloxegol Oxalate 1354744-91-4
BAY 1895344 1876467-74-1
Epoxomicin 134381-21-8
TAPI-1 171235-71-5
Trichostatin A (TSA) 58880-19-6
L-BMAA HCl 15920-93-1
TAPI-2 187034-31-7
XL888 1149705-71-4
PF1022A 133413-70-4
Ruxolitinib 941678-49-5
Batimastat(BB-94) 130370-60-4
LGD3303 917891-35-1
ARN-3236 1613710-01-2
Itacitinib; INCB039110 1334298-90-6
Upadacitinib tartrate 1607431-21-9
Fluxapyroxad 907204-31-3
Tacrolimus 104987-11-3
Ectoine 96702-03-3
M-3814 1637542-33-6
LY-3200882 1898283-02-7
AZD-4635 1321514-06-0
CNDAC HCl 134665-72-8
Umeclidinium bromide 869113-09-7
CPI-169 R-enantiomer 1802175-07-0
ML216 1430213-30-1
RG7112 939981-39-2
RSV604 676128-63-5
TD139 1450824-22-2
ARS853 1629268-00-3
EC330 2016795-77-8
(2R,3S)-rel-2,3-Bis(4-chlorophenyl)butane-2,3-diamine  939983-16-1
5-bromo-4-chloro-6-iodothieno[2,3-d]pyrimidine  1799610-89-1
Thiazovivin 1226056-71-8
GSK1349572 sodium salt 1051375-19-9
GSK1349572 1051375-16-6
MCB-613 1162656-22-5
Lorcaserin hydrochloride 846589-98-8 
PU-WS13 1454619-14-7
methyl 5-ethyl-4-hydroxy-1-methyl-2-oxoquinoline-3-carboxylate 1354639-60-3
Amenamevir 841301-32-4
MK-801 (Dizocilpine) 77086-21-6
GSK-F1 1384097-27-1
TTA-A2 953778-63-7
CMP8 851107-28-3
CLR1501 1250963-36-0
Benzamil hydrochloride 161804-20-2
iCRT-14 677331-12-3
XCT790 725247-18-7
Rhodamine 123 62669-70-9
LY-294002 hydrochloride 934389-88-5
AP-1903 195514-63-7
Troparil 74163-84-1
3-(3,5-dimethoxyphenethyl)-1H-pyrazol-5-amine 1000895-53-3
LY2857785 1619903-54-6
Delpazolid   1219707-39-7
 
  
80% of avbove listed items are kept in stock.  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Product Company   Service Company
Biopharma
- Research
Biotech
- Research
Pharmaceutical
- Research
Supplier
- Laboratory
- Research

Last update of this entry: October 03, 2019

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2020 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.